Physician profile
Mark C Wilde
NPI 1730148925
$692.27
in general payments reported to CMS, 2019-2025
10 companies · $149 in 2025
The $149 reported for 2025 was less than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.35 · 2021: $11.70 · 2022: $149 · 2023: $141 · 2024: $225 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $515.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $251.23 | 2023-2025 | Nayzilam, Rystiggo, Briviact |
| Eisai INC. | $164.41 | 2024-2025 | |
| Abbvie INC. | $125.39 | 2022 | |
| Boston Scientific Corporation | $35.48 | 2023 | Vercise |
| Irhythm Technologies, INC. | $34.21 | 2024 | Zio Monitor, Zio Xt Patch |
| Amgen INC. | $23.36 | 2022 | |
| Grt US Holding, INC. | $16.35 | 2019 | |
| Genentech USA, INC. | $15.62 | 2023 | Ocrevus |
| Avion Pharmaceuticals | $14.52 | 2023 | Dhivy |
| Ge Healthcare | $11.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Wilde listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.